×

Can US tax reform prevent inversions?

1:05 PM ET Mon, 23 Nov 2015

Pfizer's inversion with Allergan has renewed the debate around U.S. tax policy reform. American Enterprise Institute's James Pethokoukis and Budget & Policy Priorities Senior Fellow Jared Bernstein weigh in on solutions.